LINC01651

Across TCGA pan-cancer cohorts, LINC01651 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated LINC01651 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher LINC01651 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01651 expression acts as an unfavorable survival marker, although some lineages such as LUSC show a favorable association.

STAD, BLCA, and HNSC are the cancer types where LINC01651 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	IV	0.074	0.496	.002	99	view →
BLCA	OS	Tertile	All	0.183	0.720	.001	81	view →
HNSC	OS	Tertile	II,III,IV	0.059	0.712	<.001	72	view →
SARC	OS	Tertile	All	0.127	0.860	<.001	27	view →
TGCT	DFS	Tertile	All	0.078	0.673	.024	18	view →
LUSC	DFS	Tertile	II,III,IV	1.000	0.350	.044	3	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

LINC01651–STAD (OS)

Open the STAD breakdown →